Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors César Fernández-de-las-PeñasCarolina Fernández-LaoManuel Arroyo-Morales Preclinical Study 04 September 2011 Pages: 405 - 412
Thinking beyond the tumor to better understand chronic symptoms in breast cancer survivors N. Lynn HenryDaniel J. Clauw Invited Commentary 11 October 2011 Pages: 413 - 416
Effect of anti-DR5 and chemotherapy on basal-like breast cancer Patsy G. OliverAlbert F. LoBuglioDonald J. Buchsbaum Preclinical study 07 September 2011 Pages: 417 - 426
Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer Emi TokudaYuko SeinoYuri Yamaguchi Preclinical Study 11 September 2011 Pages: 427 - 436
Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity Angelina I. Londoño-JoshiPatsy G. OliverDonald J. Buchsbaum Preclinical Study 14 September 2011 Pages: 437 - 445
C6-Ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth Margaret FlowersGemma FabriásMyles C. Cabot Preclinical Study 21 September 2011 Pages: 447 - 458
The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin Osvaldo PontiggiaRocio SampayoMarina Simian Preclinical study 21 September 2011 Pages: 459 - 471
The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells Yi MaXiaomeng HaoJin Zhang Preclinical study 23 September 2011 Pages: 473 - 485
The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells Chunyu WangJulie Ann MayerPowel H. Brown Preclinical Study 24 September 2011 Pages: 487 - 500
Vascular proliferation is a prognostic factor in breast cancer Jarle B. ArnesIngunn M. StefanssonLars A. Akslen Preclinical Study 27 September 2011 Pages: 501 - 510
Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors Carmine FedeleGennaro RiccioClaudia De Lorenzo Preclinical study 27 September 2011 Pages: 511 - 521
Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice Penelope D. OttewellHannah K. BrownIngunn Holen Preclinical Study 29 September 2011 Pages: 523 - 536
Quality of life among Egyptian women with breast cancer after sparing mastectomy and immediate autologous breast reconstruction: a comparative study Adel DenewerOmar FaroukMosab Shetiwy Preclinical Study 29 September 2011 Pages: 537 - 544
A comparison of quality of life of early breast cancer patients treated with accelerated partial breast irradiation versus whole breast irradiation in China Zhen-Yu HeQin TongXun-Xing Guan Preclinical study 29 September 2011 Pages: 545 - 552
Improving communication of breast cancer recurrence risk Noel T. BrewerAlice R. RichmanLisa A. Carey Preclinical Study 01 October 2011 Pages: 553 - 561
IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways Tania BenatarWenyi YangArun Seth Preclinical study 14 October 2011 Pages: 563 - 573
EpCAM expression is an indicator of recurrence in basal-like breast cancer Ayodeji J. AgboolaE. Claire PaishAndrew R. Green Preclinical Study 15 October 2011 Pages: 575 - 582
Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours Karolina HolmJohan StaafÅke Borg Preclinical study 16 October 2011 Pages: 583 - 594
Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts P. CottuE. MarangoniD. Decaudin Preclinical study 16 October 2011 Pages: 595 - 606
GRB7 is required for triple-negative breast cancer cell invasion and survival Orsi GiriczVerónica CalvoParaic A. Kenny Preclinical Study 18 October 2011 Pages: 607 - 615
Life stage differences in mammary gland gene expression profile in non-human primates Petra StuteSonja SielkerJ. Mark Cline Preclinical study 25 October 2011 Pages: 617 - 634
Lipidomic approach to identify patterns in phospholipid profiles and define class differences in mammary epithelial and breast cancer cells M. Luísa DóriaZita CotrimM. Rosário Domingues Preclinical study 25 October 2011 Pages: 635 - 648
Epigenetic silencing of the tumor suppressor klotho in human breast cancer Tami RubinekMichal ShulmanIdo Wolf Preclinical Study 22 October 2011 Pages: 649 - 657
Rates of upgrade to malignancy for 271 cases of flat epithelial atypia (FEA) diagnosed by breast core biopsy Alexandre PeresEmmanuel BarrangerPascal Cherel Preclinical study 01 November 2011 Pages: 659 - 666
Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: a randomized controlled trial Sharon L. KilbreathKathryn M. RefshaugeRoss Hansen Clinical Trial 29 January 2012 Pages: 667 - 676
Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score Alan H. B. WuWendy LorizioElad Ziv Clinical Trial 01 February 2012 Pages: 677 - 683
Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results Shunji TakahashiTakuji IwaseShinzaburo Noguchi Clinical Trial 04 February 2012 Pages: 685 - 693
Which prediction models best identify additional axillary disease after a positive sentinel node biopsy for breast cancer? Tanya S. BerrangMary LesperanceIvo A. Olivotto Clinical Trial 25 February 2012 Pages: 695 - 702
Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence Yi Ling TeoManit SaetaewAlexandre Chan Clinical Trial 28 February 2012 Pages: 703 - 711
Invasive lobular breast cancer: subtypes and outcome Monica IorfidaEugenio MaioranoGiuseppe Viale Clinical Trial 08 March 2012 Pages: 713 - 723
Molecular and clinical characterization of an in frame deletion of uncertain clinical significance in the BRCA2 gene Michelle G. RathFarnoosh Fathali-ZadehBarbara Burwinkel Epidemiology 08 January 2012 Pages: 725 - 734
Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening Kelly A. MetcalfeNida MianSteven A. Narod Epidemiology 13 January 2012 Pages: 735 - 740
Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes Byeong-Woo ParkSeho ParkKyong Sik Lee Epidemiology 29 January 2012 Pages: 741 - 751
Health-related quality of life in male breast cancer patients Christoph KowalskiPetra SteffenHolger Pfaff Epidemiology 08 February 2012 Pages: 753 - 757
Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan Masahide KondoShu-Ling HoshiMasakazu Toi Epidemiology 08 February 2012 Pages: 759 - 768
The single-nucleotide polymorphisms +936 C/T VEGF and −710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population Patricia RodriguesJessica FurriolPilar Eroles Epidemiology 08 February 2012 Pages: 769 - 778
Increased diagnosis and detection rates of carcinoma in situ of the breast J. A. GloverF. J. BannonL. J. Murray Epidemiology 14 February 2012 Pages: 779 - 784
Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Catherine A. McCartyDouglas J. RedingRegina G. Ziegler Epidemiology 14 February 2012 Pages: 785 - 792
Importance of highly selective LC–MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen N. G. L. JagerH. RosingJ. H. Beijnen Brief Report Open access 03 March 2012 Pages: 793 - 798
Mesothelin, a novel immunotherapy target for triple negative breast cancer Julia TchouLiang-Chuan WangPaul J. Zhang Brief Report 15 March 2012 Pages: 799 - 804
The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians Irene CatucciPaolo VerderioPaolo Peterlongo Letter to the Editor 14 March 2012 Pages: 805 - 807
Germline mutations 657del5 and 643C>T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women Martin MatejuPetra KleiblovaPetr Pohlreich Letter to the Editor 11 April 2012 Pages: 809 - 811